期刊
AMERICAN HEART JOURNAL
卷 162, 期 6, 页码 973-980出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2011.05.024
关键词
-
资金
- NIH NHLBI [U01 HL087318-01]
- Production Assistance for Cellular Therapies (PACT) [N01-HB-37164, HHSN268201000008C]
- NIH [P30 CA77598]
Moderate improvements in cardiac performance have been reported in some clinical settings after delivery of bone marrow mononuclear cells to patients with cardiovascular disease. However, mechanistic insights into how these cells impact outcomes are lacking. To address this, the National Heart, Lung and Blood Institute (NHLBI) Cardiovascular Cell Therapy Research Network (CCTRN) established a Biorepository Core for extensive phenotyping and cell function studies and storing bone marrow and peripheral blood for 10 years. Analyzing cell populations and cell function in the context of clinical parameters and clinical outcomes after cell or placebo treatment empower the development of novel diagnostic and prognostics. Developing such biomarkers that define the safety and efficacy of cell therapy is a major Biorepository aim. (Am Heart J 2011;162:973-80.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据